KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Cash from Investing Activities (2016 - 2026)

Palvella Therapeutics has reported Cash from Investing Activities over the past 9 years, most recently at $1.1 million for Q4 2022.

  • Quarterly Cash from Investing Activities rose 423.68% to $1.1 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was -$21.2 million through Dec 2022, down 2137.72% year-over-year, with the annual reading at $12.0 million for FY2023, 156.52% up from the prior year.
  • Cash from Investing Activities was $1.1 million for Q4 2022 at Palvella Therapeutics, down from $5.5 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $53.4 million in Q3 2018 and troughed at -$48.8 million in Q2 2018.
  • The 5-year median for Cash from Investing Activities is -$128500.0 (2021), against an average of $899500.0.
  • Year-over-year, Cash from Investing Activities surged 18576.82% in 2018 and then crashed 60428.57% in 2022.
  • A 5-year view of Cash from Investing Activities shows it stood at -$5.2 million in 2018, then soared by 63.94% to -$1.9 million in 2019, then soared by 889.53% to $14.9 million in 2020, then plummeted by 102.3% to -$342000.0 in 2021, then surged by 423.68% to $1.1 million in 2022.
  • Per Business Quant, the three most recent readings for PVLA's Cash from Investing Activities are $1.1 million (Q4 2022), $5.5 million (Q3 2022), and -$10.9 million (Q2 2022).